2-(tert-Butyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

Catalog No. :
ACKQXJ230
CAS No. :
2223047-95-6
Molecular Formula :
C15H24BNO2
Molecular Weight :
261.17

IUPAC Name:2-(tert-butyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

2-(tert-Butyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$237.00Login to see priceInquiryInquiry
250mg97%$412.00Login to see priceInquiryInquiry
1g97%$827.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(tert-Butyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
IUPAC Name2-(tert-butyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
MDL No.MFCD12032524
Molecular FormulaC15H24BNO2
Molecular Weight261.17
SMILESCC1(C)C(C)(C)OB(C2=CN=C(C(C)(C)C)C=C2)O1
InChI KeyLXORPDKZCWAYIC-UHFFFAOYSA-N
Synonym6-(TERT-BUTYL)PYRIDINE-3-BORONIC ACID PINACOL ESTER;2-tert-Butyl-pyridine-5-boronic acid picol ester;2-(Tert-butyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;Pyridine, 2-(1,1-dimethylethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.2223047-95-6

Synthetic Route by SureRoute

1. ACKQXJ230 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACORTG072 route compound structure diagram
    ACORTG07239919-58-9 In Stock
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACKQXJ230 route product structure diagram
    ACKQXJ2302223047-95-6
Inquiry

2. ACKQXJ230 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACKQXJ230 route product structure diagram
    ACKQXJ2302223047-95-6
Inquiry

Comments (0)